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Branching of ureteric bud-derived epithelial tubes is a key morphogenetic process that shapes development of the kidney. Glial cell line-
derived neurotrophic factor (GDNF) initiates ureteric bud formation and promotes subsequent branching morphogenesis. Exactly how GDNF
coordinates branching morphogenesis is unclear. Here we show that the absence of the receptor tyrosine kinase antagonist Sprouty1 (Spry1) results
in irregular branching morphogenesis characterized by both increased number and size of ureteric bud tips. Deletion of Spry1 specifically in the
epithelium is associated with increased epithelial Wnt11 expression as well as increased mesenchymal Gdnf expression. We propose that Spry1
regulates a Gdnf/Ret/Wnt11-positive feedback loop that coordinates mesenchymal–epithelial dialogue during branching morphogenesis. Genetic
experiments indicate that the positive (GDNF) and inhibitory (Sprouty1) signals have to be finely balanced throughout renal development to
prevent hypoplasia or cystic hyperplasia. Epithelial cysts develop in Spry1-deficient kidneys that share several molecular characteristics with those
observed in human disease, suggesting that Spry1 null mice may be useful animal models for cystic hyperplasia.
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doi:10.1016/j.ydbio.2006.08.051normal renal organogenesis is underscored by the demonstra-
tion that mutations affecting this process often result in kidney
malformations such as multicystic renal dysplasia and hypo-
plasia (Matsell et al., 1996; Piscione and Rosenblum, 2002).
The first step in kidney development is the outgrowth of the
ureteric bud (UB) from the caudal Wolffian duct (WD) (Saxen,
1987). UB outgrowth is induced by GDNF (Moore et al., 1996;
Pichel et al., 1996; Sainio et al., 1997; Sanchez et al., 1996;
Towers et al., 1998; Vega et al., 1996) in a process regulated by
Sprouty1 (Spry1) (Basson et al., 2005). Reciprocal signaling
between the UB epithelium and metanephric mesenchyme
(MM) regulates subsequent growth and branching morphogen-
esis of the UB-derived epithelial tubes to form a tree-like
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system of the kidney. Multiple growth factors expressed in the
metanephric mesenchyme have been proposed to play roles in
morphogenesis of the ureteric tree (Schedl and Hastie, 2000). In
particular, both in vitro and in vivo data provide compelling
evidence for a central role for glial cell line-derived neuro-
trophic factor (GDNF) in orchestrating branching morphogen-
esis (Michael and Davies, 2004; Moore et al., 1996; Pepicelli et
al., 1997; Pichel et al., 1996; Sanchez et al., 1996; Towers et al.,
1998; Vega et al., 1996). The GDNF receptor RET and co-
receptor GFRα1 are highly expressed in the tips of the
branching ureteric tree and mice lacking these genes have
severe defects in both ureteric bud formation and branching
(Cacalano et al., 1998; Schuchardt et al., 1994). Furthermore, a
proportion of Gdnf heterozygous mice exhibit unilateral renal
agenesis or hypoplasia, indicating that kidney development is
highly sensitive to modest changes in GDNF signaling (Cullen-
McEwen et al., 2001; Moore et al., 1996; Pichel et al., 1996;
Sanchez et al., 1996). Finally, blockade of GDNF/RET
signaling during the culture of kidney rudiments in vitro
inhibits branching morphogenesis (Davies et al., 1999;
Ehrenfels et al., 1999; Fisher et al., 2001; Vega et al., 1996).
Thus, a likely explanation for the reduction in kidney size in
Gdnf+/−mice is a paucity of branching of the ureteric epithelium
during development. In vitro evidence also suggests a role for
members of the fibroblast growth factor (Fgf) family in
branching morphogenesis (Qiao et al., 2001). In vivo support
for this notion is provided by the demonstration that mice
lacking Fgf7 or Fgf10 have smaller kidneys due to reduced
branching morphogenesis of the ureteric tree (Ohuchi et al.,
2000; Qiao et al., 1999). Similar defects are found in mice in
which Fgfr2 is deleted in the ureteric epithelium (Zhao et al.,
2004). Finally, overexpression of a human Spy2 transgene in
mouse kidneys interferes with GDNF- and FGF-induced
branching morphogenesis (Chi et al., 2004).
Ectopic ureteric buds develop in the majority of embryos
lacking the receptor tyrosine kinase antagonist, Spry1 (Basson
et al., 2005), indicating an important role for this gene in the
initiation of renal development. We now show that Spry1
mutant kidneys have defects in every generation of branching
morphogenesis of the ureteric tree irrespective of whether the
kidneys are derived from a single or multiple ureteric buds. We
conclude that Spry1 functions throughout kidney development
to regulate GDNF/RET-mediated epithelial morphogenesis.
Materials and methods
Mice
Spry1 null (Spry1−) and conditional null (Spry1flox) mice (Basson et al.,
2005) were maintained on a mixed genetic background. Tissue-specific
knockouts were generated by breeding Spry1flox/flox females to Hoxb7-cre;
Spry1flox/+ males (Yu et al., 2002). Mice carrying a Gdnf null allele (Sanchez et
al., 1996), were crossed to the Spry1+/− animals. Spry1+/−;Gdnf+/− males were
bred to Spry1+/− females to produce embryos and newborns that were analyzed
for defects in kidney development. All experiments involving animals were
approved by the Mount Sinai School of Medicine and Columbia University
Institutional Animal Care and Use Committees (USA) and the Home Office
(UK).Immunohistochemistry
Newborn kidneys were fixed with 4% paraformaldehyde in PBS for 2–4 h at
4°C, embedded in wax and 7 μm sections cut. After dewaxing and rehydration,
sections were stained for 1.5 h at room temperature with primary antibodies
specific for PAX2 (Covance, Cambridge Bioscience, Cambridge, UK), dipho-
sphorylated ERK (Cell signaling, NEB, UK), phospho-histone H3 (Upstate
Biotechnology, Lake Placid, NY), E-cadherin (RDI, Flanders, NJ), β-catenin
(BD Transduction Labs, BD Biosciences, San Jose, CA) and polycystin-1
(Wilson et al., 1999). Antibody stains were developed using the Vector ABC
Elite system followed by a DAB (3,3′-diaminobenzidine) or AEC color reaction
according to the manufacturer's instructions (Vector Labs, Burlingame, CA).
DAB-stained sections were counterstained with hematoxylin. For fluorescent
detection, sections were stained with Alexa 488- or Alexa 568-conjugated
species-specific secondary antibodies (Molecular Probes, Invitrogen, Carlsbad,
CA) and examined on a Zeiss Axioskop2 mot plus confocal microscope
equipped with LSM5 Pascal lasers.
Transmission electron microscopy
Portions of wild-type and Spry1 mutant kidneys were fixed in 3%
glutaraldehyde in a 0.2 M sodium cacodylate buffer and embedded in Embed
812 plastic resin (Electron Microscopy Sciences, Hatfield, PA). One-micrometer
plastic sections were cut, stained with methylene blue and azure II and observed
by light microscopy. Representative areas were chosen for ultrathin sectioning.
The ultrathin sections were stained with uranyl acetate and lead citrate. The
sections were observed on a H7000 Hitachi transmission electron microscope.
Metanephric kidney organ cultures
Metanephric kidneys were dissected from embryonic day (E)11.5 embryos
in ice-cold CO2-independent medium (Gibco, Invitrogen, Paisley, UK)
containing 1% fetal bovine serum (Gibco, Invitrogen, Paisley, UK). Explants
were cultured in DMEM (Gibco) supplemented with 290 μg/ml glutamine,
100 U/ml penicillin, 100 μg/ml streptomycin, 10% fetal bovine serum in a 5%
CO2 at 37°C in a humidified atmosphere at the medium-air interface on Costar
Transwell filters (0.4 μm). After culture, explants were fixed either in methanol
for immunostaining or 4% paraformaldehyde in PBS for in situ hybridization.
For immunostaining, explants were stained with anti-cytokeratin (Sigma,
Surrey, UK) as described previously (Basson et al., 2005). Images were captured
on a Zeiss Axioskop microscope attached to a Colorview12 digital camera. GFP
expressing embryonic mouse kidneys were fixed for 1 h in 4% paraformalde-
hyde at room temperature. The kidneys were cleared with FocusClear (PacGen
Biopharmaceuticals, Inc., Vancouver, BC, Canada) for 20 min at room
temperature, then mounted in MountClear (PacGen) between 25 mm coverslips
separated by a silicone spacer (Grace Bio-Labs, Bend, OR). Kidneys were
examined with a Bio-Rad laser scanning confocal microscope equipped with a
10× water immersion lens, NA 0.3. Image stacks were collected by optically
sectioning the kidneys at 4.4-μm intervals. Image stacks were volume-rendered
using Volocity Software (Improvision, Lexington, MA).
GFP time-lapse videography
E11.5 kidney rudiments from Hoxb7-eGFP;Spry1+/− by Spry1+/− crosses
were cultured and time-lapse recordings were taken as described previously
(Srinivas et al., 1999a; Watanabe and Costantini, 2004). Images were collected
every 30 min for a 24-h period. To estimate the kinetics of branching
morphogenesis and growth, the relative length of the ureteric bud generations
was measured as described (Watanabe and Costantini, 2004). In addition,
individual branched tips were counted at 5-h intervals.
Whole-mount in situ hybridization
Tissue was fixed overnight in 4% paraformaldehyde in PBS at 4°C. In situ
hybridization was carried out as described (Grieshammer et al., 2004). Probes
for Gdnf were as described (Srinivas et al., 1999b), with the addition of a shorter
Gdnf probe (Grieshammer et al., 2004). The Wnt11 probe (Majumdar et al.,
468 M.A. Basson et al. / Developmental Biology 299 (2006) 466–4772003) was kindly provided by A. McMahon (Harvard University, USA), the
Spry1 and Spry2 probes (Minowada et al., 1999) by G. Martin (University of
California, San Francisco, USA) and the erm probe (Hippenmeyer et al., 2002)
was from Silvia Arber (University of Basel, Switzerland).
Biochemical analysis of GDNF signaling pathways
The mouse inner medullary collecting duct cell line (mIMCD3) was
transfected with a pSIREN-RetroQ vector (Clontech, Palo Alto, CA) containing
19 base long inserts corresponding to nucleotides 226–244 (relative to Spry1
translation start site) of mouse Spry1 or inserts of random sequence as a control
(Hammond et al., 2001). 48 h after transfection, short-term selection was started
with 2 mg/ml puromycin (Sigma). 72 h later cells were serum starved for 24 h
and stimulated with 100 ng/ml GDNF (R&D systems) for the indicated time
intervals. Cells were lysed in ice-cold lysis buffer (1% Triton X-100, 0.1% SDS,
150 mM NaCl, 50 mM Tris–HCl (pH 7.4), 10 mM NaF, 2 mM sodium
orthovanadate and one tablet of complete protease inhibitors for 50 ml (Roche)).
The resulting proteins (50 μg) were resolved by SDS-polyacrylamide gel
electrophoresis and transferred to Immobilon-P membranes (Millipore). The
membranes were probed with antibodies against phospho-44/42 MAP kinase
(Santa Cruz), GAPDH (Chemicon) and Sprouty1 as described (Gross et al.,
2001).
Estimation of newborn kidney sizes
Freshly dissected newborn kidneys were measured in two dimensions:
length along the long axis, and width (from point of ureter entry to the outside
edge). The volumes of newborn kidneys were estimated using the following
equation: estimated volume (mm3)=length (mm)×width2 (mm)2/2 (Gilbert et
al., 2003).Results
Abnormal branching morphogenesis of Spry1 null ureteric
epithelium
We previously described defects in ureteric bud formation
in Spry1-deficient embryos at the initiation of metanephricFig. 1. Three-dimensional reconstruction of the structure of the ureteric tree of Hoxb
imaged by confocal microscopy. Three-dimensional renderings from 110 confocal o
orientated to the right. Panels a–c show 25 volume-rendered confocal sections throu
panels B, b indicate abnormal ureteric tree tips in the anterior poles of the mutant kkidney development (Basson et al., 2005). Whereas most
adult Spry1−/− animals exhibited bi- or unilateral multiplex
kidneys due to the production of supernumerary ureteric buds in
the embryo, a significant percentage (28%, n=25) of Spry1−/−
kidneys were attached to a single ureter. RTK signaling
pathways are utilized throughout branching morphogenesis
and the overexpression of Spry2 inhibits this process (Chi et al.,
2004). Therefore, Spry1−/− kidneys that developed from single
ureteric buds, provided us with the opportunity to examine
Spry1 function during branching morphogenesis independently
of defects that might be secondary to the formation of ectopic
ureteric buds.
We produced control (Spry1+/−) and mutant (Spry1−/−)
embryos that contained a Hoxb7-eGFP transgene (Watanabe
and Costantini, 2004). The three-dimensional structures of
E14.0 kidney rudiments from these animals, that express GFP
throughout the ureteric epithelium, were examined by confocal
microscopy. The mutant kidneys displayed more numerous
ureteric bud tips, irrespective of whether kidney primordia were
derived from single (Fig. 1B, b) or multiple ureteric buds (Fig.
1C, c) (see below for quantitative analyses). In addition, we
observed a number of ureteric tree branches that failed to swell
and bifurcate as they reached the perimeter of the kidney
(asterisk in Fig. 1B, b). Thus, branching morphogenesis was
quantitatively and qualitatively abnormal in the absence of
Spry1, even when the ureteric tree was derived from a single
UB.
The analyses of ex vivo kidney rudiments only provide
information at a single developmental end-point. In vitro
culture of early rudiments can faithfully recapitulate in vivo
development and allows the study of branching morphogenesis
in real time. Therefore, we isolated embryonic kidney rudiments
at E11.5 and cultured them in vitro for 48 h. The ureteric tree in
cultured Spry1−/− metanephric kidneys that developed from7-eGFP;Spry1+/− (A, a) and Hoxb7-eGFP;Spry1−/− (B, b; C, c) kidneys at E14
ptical sections are shown in panels A–C, with the anterior poles of the kidneys
gh the center of the corresponding kidneys shown in panels A–C. Asterisks in
idneys and arrows in panels C, c indicate supernumerary ureters.
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pattern (Figs. 2A, B). In addition, the ureteric bud tips in
Spry1−/− kidneys were dilated (Figs. 2A′, B′) and the branching
pattern was highly irregular compared to controls. While it also
appeared as if some tips might be fused at the perimeter of the
developing kidneys (Figs. 2B, B′), confocal analysis indicated
that the enlarged branch tips were overlapping yielding the
abnormal appearance of these specimens (not shown).
Spry1 is expressed in the ureteric tree and at much lower
levels in the condensing mesenchyme of the developing
metanephric kidney (Gross et al., 2003; Zhang et al., 2001)
(Fig. 2E). To determine the primary site of Spry1 function
during branching morphogenesis, we examined the develop-
ment of metanephric kidneys in which the Spry1 gene was
deleted only in the ureteric tree through the action of a Hoxb7-
cre transgene (Yu et al., 2002). Our prior work indicated that
deletion of Spry1 in the Wolffian duct resulted in the formation
of multiple ureters in nearly 3/4 mice (Basson et al., 2005). To
avoid the effects of these multiple ureters, we focused on the
phenotype of E11.5 Hoxb7-cre;Spry1flox/flox kidney explants
derived from single ureteric buds. After in vitro culture for 40 h
these conditional null kidney explants demonstrated a perturbed
branching pattern characterized by wide ureteric trunks and tips,
similar to that of Spry1−/− explants (Figs. 2C, D). This result
indicated that Spry1 functions continuously in the ureteric
epithelium after initial ureteric bud formation to regulate
branching morphogenesis. Furthermore, this result demontrates
that these ureteric tree anomalies were not secondary to the loss
of Spry1 expression in the metanephric mesenchyme. In situ
hybridization of these metanephric kidney explants using a
Spry1 probe to a portion of the open reading frame (Minowada
et al., 1999) confirmed that the gene had been deleted from the
ureteric bud epithelium, whereas expression in the metanephric
mesenchyme remained intact (Figs. 2E, F).Fig. 2. Branching morphogenesis defects in Spry1−/− and Hoxb7-cre;Spry1flox/flox me
(B, B′) branched ureteric trees after 48-h in vitro culture of E11.5 kidney explants. No
mutant (B) organs. Wide, abnormally shaped ureteric bud tips (higher magnificati
Comparison between Hoxb7-cre, Spry1flox/+ (C) and Hoxb7-cre;Spry1flox/flox (D) E11
asterisks in panel D. (E, F) Spry1 in situ hybridization indicating normal Spry1 mR
(MM) (E), and specific loss of expression in the UB in Hoxb7-cre;Spry1flox/flox kidnTime-lapse analysis of branching morphogenesis reveals
increased growth of Spry1 mutant kidneys
Time-lapse photography was employed to explore the
dynamics of the branching process in real time during in vitro
culture (Watanabe and Costantini, 2004). Two Spry1−/− E11.5
kidney rudiments are shown in Fig. 3: (a) an explant with
supernumerary buds (Fig. 3A, arrow) and (b) an explant with a
single major ureteric bud. Note that in both cases the mutant
ureteric bud tips were significantly wider than controls (Fig.
3Aa, b and (Basson et al., 2005)). During a 24-h culture period,
control ureteric buds branched in a reiterative fashion to
produce ureteric trees composed of regularly spaced tips of
similar sizes (Fig. 3A and Supplementary Movie 1A). The
mutant kidneys clearly did not follow this stereotypical
branching morphogenesis program regardless of the presence
or absence of extra ureteric buds (Fig. 3A and Supplement Figs.
1B, C). In the Spry1−/− rudiments, ureteric bud tips were
significantly larger in length and caliper than in the controls and
instead of undergoing mainly dichotomous branching, these
wide ureteric bud stalks and tips formed multiple outbuddings
resulting in highly irregular structures at the end of the culture
(Fig. 3A and Supplementary Movie 1B, C).
Measuring the lengths of ureteric bud segments at each
branch generation and summing these branch lengths showed a
slow, steady growth rate in wild-type kidneys and a 2- to 3-fold
greater rate of elongation in mutant kidneys (Fig. 3B). Some of
the kidneys even showed five branch generations while the
wild-type kidneys only displayed four ramifications in an
equivalent period of in vitro culture (Fig 3B). In the Spry1−/−
kidneys the 4th generation of branching, beginning at 15 h of
culture was accentuated and growth appeared to accelerate after
this point. The number of ureteric bud tips also rapidly
increased in Spry1−/− ureteric buds between 15 and 24 h oftanephric kidneys. (A, B) A comparison between Spry1+/− (A, A′) and Spry1−/−
te the regular, reiterative branching pattern in control (A) vs. irregular pattern in
on in panel B′) are indicated by asterisks in the Spry1−/− kidney (B). (C, D)
.5 kidneys after 40-h culture. Note the wide, irregularly shaped tips, indicated by
NA expression in the ureteric bud tips (UB) and the metanephric mesenchyme
ey explants at ~E13.5 (F).
Fig. 3. Analyses of ureteric bud branching morphogenesis in real-time using a Hoxb7-eGFP transgene. (A) E11.5 (0 h) Hoxb7-eGFP;Spry1+/+ ureteric buds are
T-shaped at the beginning of culture. Iterative branching morphogenesis results in a tree-like structure with regularly spaced tips after 24 h. Two E11.5 Hoxb7-
eGFP;Spry1−/− explants are shown. The top panel (a) shows an example of a wide, abnormally shaped ureteric bud with a clear ectopic ureteric bud (arrow) in an
explant. The wide ureteric bud forms multiple bud tips by 15 h that grow and branch further to result in a highly complex, abnormal structure after 24 h. The
ectopic ureteric bud initiates some branching morphogenesis after 24 h. An example of a Hoxb7-eGFP;Spry1−/− explant that has a relatively normal T-shaped
ureteric bud at E11.5 is shown in the bottom panel (b). By 15 h multiple bud tips are observed (asterisks) that results in an abnormal ureteric structure after 24 h
of culture. (B) Relative UB segment length was determined for each branch generation and a representative plot of the data is presented. Note the rapid increase
in growth during the fourth generation branching of the mutant kidneys. Black linear regression lines with indicated slopes demonstrate the overall growth rate of
the entire ureteric tree. (C) The number of ureteric bud tips was counted at each 5 h of culture to reveal increased rate of bud tip production in Spry1−/− explants
between 15 and 24 h of culture compared to controls. See Supplementary data for real-time movies.
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continuing role for Spry1 in regulating the extent and rate of
ureteric bud branching morphogenesis.
Abnormalities in gene expression during ureteric branching
morphogenesis
The formation of dilated, almost cystic ureteric bud tips with
multiple outbuddings is remarkably similar to anomalies in
ureteric bud branching produced upon implantation of GDNF
beads into normal kidney explants (Pepicelli et al., 1997) (http://
cpmcnet.columbia.edu/dept/genetics/kidney/movies.html).We therefore investigated whether or not the Spry1−/−
mutant kidney explants displayed aberrant expression of genes
of the GDNF/RET signaling pathway. Gdnf expression is
normally restricted to the metanephric mesenchyme surround-
ing ureteric bud tips (Hellmich et al., 1996; Suvanto et al.,
1996). Surprisingly, the expression of Gdnf appeared more
abundant and in a more extensive portion of the Spry1−/−
mesenchyme (compare Figs. 4A, A′ with B, B′). Wnt11
expression is normally induced in ureteric bud tips upon
activation of RET by GDNF (Pepicelli et al., 1997) and genetic
experiments have confirmed that Wnt11 is almost absent in
Ret−/− kidneys (Majumdar et al., 2003). In the absence of Spry1,
Fig. 4. In situ hybridization for Gdnf and Wnt11 mRNA indicates hyperactivation of GDNF/RET/WNT11 signaling loop. (A, B) Comparison of Gdnf expression in
Spry1+/− with Spry1−/− E11.5 explants after 48 h of culture. (A′, B′) Higher power views of panels A and B, respectively. (C, D) Wnt11 expression in Spry1+/− and
Spry1−/− kidney explants. (C′, D′) Higher power views of panels C and D, respectively indicating the expansion of Wnt11 expression to ureteric stalks connecting
individual ureteric bud tips (asterisks) in the mutant (arrow in panel D′). (E, F) Comparison of Gdnf and Wnt11 (G, H) expression between Hoxb7-cre;Spryflox/+ and
Spry1flox/flox explants. Inset in panel H shows a higher power view of the indicated area to show expansion of Wnt11 expression to ureteric stalks (arrow). Scale
bars=200 μm, apart from panels C′ and D′ where they are 100 μm.
471M.A. Basson et al. / Developmental Biology 299 (2006) 466–477Wnt11 mRNA was often detected in the connecting segments
between tips further apart than 200 μm. In Spry1+/− explants,
Wnt11 expression does not persist in stalk areas between tips
once the ureteric tree has grown to the point where tips are moreFig. 5. The loss of Spry1 results in hyperactive RTK signaling. The expression of ge
between control Spry1+/− and mutant Spry1−/− kidney explants. (E) Immunoblots of w
shRNA, stimulated with GDNF and blotted with antibodies to activated phospho-AK
shown. Note that both AKT and ERK1/2 were hyperactivated in cells with reducedthan 200 μm apart (compare Figs. 4C, C′ with Figs. 4D, D').
This result suggested that these cells experienced increased
GDNF signaling. A positive autoregulatory feedback loop that
regulates Gdnf, Ret and Wnt11 expression was describednes downstream of RTK signaling, Spry2 (A, B) and erm (C, D) were compared
hole cell lysates from mIMCD3 cells transfected with Spry1-specific or control
T (P-AKT), activated phospho-ERK1/2 (P-ERK1/2), SPRY1 and GAPDH are
amounts of SPRY1.
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comes from the observation that Gdnf expression is drastically
reduced inWnt11−/− kidneys (Majumdar et al., 2003). Thus, the
expanded mesenchymal Gdnf expression in Spry1 mutant
kidneys may be secondary to the hypersensitivity of ureteric
epithelium to GDNF signals. In this scenario, increased and
ectopic Wnt11 expression in the ureteric tree induces Gdnf
upregulation in the mesenchyme, thus closing the positive
feedback loop resulting in perpetuation of elevated GDNF/RET
signaling (see Fig. 8).
In order to obtain evidence for such a mechanism, we
also examined Gdnf and Wnt11 expression in Hoxb7-cre;
Spry1flox/flox kidney explants. In these kidneys where Spry1
had been deleted only in the ureteric bud, we also observed a
significant expansion of Gdnf mRNA expression throughout
the mesenchyme (Figs. 4E, F), indicating that upregulation of
Gdnf message in the mesenchyme occurred in response to
deregulated GDNF/RET signaling in the ureteric bud and was
not due to the loss of Spry1 in the mesenchyme. Wnt11 was
also abnormally expressed in the ureteric epithelium in
between buds, suggesting that the absence of Spry1 resulted
in hypersensitivity to RET-mediated signals (Figs. 4G, H).
Increased RTK signaling in the absence of Spry1
To find more evidence that the ureteric epithelium is
subjected to increased RTK signaling in the absence of Spry1,
we analyzed the expression of genes normally regulated byFig. 6. Branching morphogenesis of the ureteric tree is regulated by the interplay be
indicated genotypes are shown. (A′–E′) Representative ureteric trees in E11.5 metane
shown for each of the genotypes. Note that relatively normal branching patterns corre
efficiency of growth and branching morphogenesis and newborn kidney sizes. (F
differences (two-tailed T test) in the size of Spry1+/+, Gdnf+/−, compound heterozygthese signals. The expression of Spry2 was slightly increased in
Spry1-deficient kidneys (Figs. 5A, B), whereas erm (Hippen-
meyer et al., 2002) was significantly upregulated (Figs. 5C, D).
To directly demonstrate the ability of Spry1 to affect GDNF/
RET signaling we used a shRNA vector to reduce Spry1
expression in the IMCD3 kidney inner medullary renal
collecting duct cell line. Upon stimulation of serum-starved
cells with GDNF, both phospho-ERK as well as phospho-AKT
were elevated in cells depleted for Spry1 relative to cells
transfected with a control shRNA vector (Fig. 5E). These data
demonstrate that in accordance with the gene expression data,
Spry1 inhibits the signaling pathways activated by GDNF. The
results further indicate that Spry1 can interfere with multiple
signaling pathways downstream of the receptor tyrosine kinase,
RET.
The Spry1 and Gdnf genes interact during branching
morphogenesis to regulate kidney size
The data presented thus far suggested that the branching
morphogenesis defects in Spry1-deficient kidneys were due to
hyperresponsiveness to GDNF/RET signaling. To find genetic
evidence to confirm this hypothesis, we compared the
phenotypes of Spry1−/− and Spry1−/−;Gdnf+/− embryonic
kidneys. The highly irregular branching pattern of Spry1−/−
kidneys, characterized by dilated and ectopic segments of the
ureteric tree was significantly normalized when the Gdnf gene
dosage was reduced (Figs. 6A′–C′). This observation providedtween Gdnf and Spry1. (A–E) Newborn kidneys and urogenital tracts with the
phric kidney explants cultured for 48 h and stained for cytokeratin expression, are
lated with the formation of normal newborn kidneys and the correlation between
) Newborn kidney volumes were estimated and show statistically significant
ote Gdnf+/−;Spry1+/− and Gdnf+/−;Spry1−/− kidneys.
473M.A. Basson et al. / Developmental Biology 299 (2006) 466–477direct genetic evidence for the hypothesis that deregulation of
GDNF/RET signaling was responsible for abnormal branching
morphogenesis of Spry1−/− ureteric tree at time points later than
the initial branching from the Wollfian duct.
Gdnf+/− mice frequently display unilateral kidney agenesis
and the kidneys that do form in such mice are small (Cullen-
McEwen et al., 2001). These observations suggested that
ureteric bud development might be sensitive to relatively
subtle changes in the dose of GDNF. In order to address this
possibility, we examined a number of Gdnf+/− kidneys and
explants. A significant proportion (n=15/39) of Gdnf+/−
kidneys were severely hypoplastic (defined as 50% smaller
than the average wild-type or Spry1+/− kidney) (Fig. 6D),
compared to 0/45 of Gdnf+/+ kidneys (Fig. 6A). Moreover,
Gdnf+/− kidney explants fail to branch more than twice during
a 48-h culture period (Fig. 6D′), confirming that ureteric bud
branching morphogenesis was sensitive to reduced levels of
GDNF. By contrast only 4/51 of Gdnf+/−;Spry1+/− kidneys
showed such extreme hypoplasia (Fig. 6E), indicating a
significant (p=0.0018 vs. Gdnf+/−) rescue of the Gdnf+/−
phenotype. As expected, Gdnf+/−;Spry1+/− explants (Fig. 6E′)
showed a branching pattern comparable to normal kidneys
(Fig. 6A′).Fig. 7. Renal epithelia in newborn Spry1−/− kidneys exhibit structural and molecul
anterior (A) portions of mutant kidneys (asterisks) that are attached to obstructed ure
to normal, draining ureters only contain a few small cysts (blue) (Ichikawa et al.,
Spry1−/− newborn animal showing multiplex kidneys and renal cysts. Note the p
structural alterations characteristic of human cystic kidney diseases are compared
kidneys. E-cadherin (E-cad) is highly expressed in all control tubular epithelium ce
panel D). Transmission electron micrographs (TEM) show regular adhesions of
knockouts (arrow in panel F). High PAX2 expression (brown) in nephrogenic zones
Many cystic epithelial cells contain high levels of diphosphorylated ERK (P-Erk)
detected in control tissue (K) by an antibody to phospho-histone H3 (P-HIS), wheWe also compared estimated mean kidney sizes of the
different genotypes. On average Gdnf+/− newborn kidneys were
38% smaller than control Spry1+/+ or Spry1+/− kidneys
(p=0.002). Upon deletion of one allele of Spry1, the average
size of the Gdnf+/−;Spry1+/− kidneys increased by 35% but
remained smaller than wild-type kidneys. Deleting the second
allele of Spry1 yielded another 52% increase in estimated
kidney volume yielding kidneys comparable in size to wild type
(Fig. 6F). This indicates that Spry1 affects Gdnf function in
kidney development in a dose-dependent manner and show that
Spry1 and Gdnf operate closely together to orchestrate
branching morphogenesis of the ureteric tree during kidney
development.
Sprouty1 null mice as an experimental model for cystic renal
hyperplasia
The majority of Spry1−/− mice are born with multiple
ureters, hydroureter and multiplex, disorganized kidneys that
often contain large epithelial cysts (Figs. 7A, B) (Basson et al.,
2005). Different types of cystic kidney disease can be classified
by the segment of the nephron or collecting system that is
affected (Wilson, 2004). Dolichus biflorus agglutinin (DBA)ar changes characteristic of cystic kidney disease. (A) Diagram showing how
ters develop large cysts (pink), whereas the more posterior (P) portions attached
2002). (B) H&E stained sections through both kidneys from a representative
revalence of large cysts in the anterior renal lobes (asterisks). Molecular and
between control Spry1+/− (C, E, G, I, K) and mutant Spry1−/− (D, F, H, J, L)
lls (C) whereas patches of cells have lost expression in the mutants (arrows in
epithelial cells to the basement membrane (arrow in panel E), disrupted in
of control kidneys (G) and in epithelia lining renal cysts (asterisks in panel H).
(J), which is undetectable in control tissue (I). Few actively cycling cells are
reas most cystic epithelial cells (L) are actively cycling.
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animals were derived from the collecting system of the kidney
(not shown). The collecting system develops from the ureteric
bud, suggesting that defects in the embryonic ureteric
epithelium may underlie this phenotype. However, macroscopic
cysts were not distributed evenly throughout many of the
mutant kidneys, but were present mainly in the anterior poles of
the mutant kidneys that were attached to abnormal ureters (Figs.
7A, B). These observations support the conclusion made from
human and experimental models that ureteric obstruction is
associated with the formation of renal cysts (Ichikawa et al.,
2002; Woolf et al., 2004). However, smaller cysts were evident
throughout the mutant kidneys (Figs. 7A, B) suggesting that
defects in morphogenesis of the ureteric tree may also
predispose the collecting system to cyst formation.
We further characterized the nature of the epithelial cysts in
Spry1−/− kidneys to determine to what extent the Spry1−/− cysts
resemble those observed in human cystic kidney diseases.
Alterations in adhesive properties of tubular epithelial cells may
be associated with the development of cystic phenotypes in
polycystic and possibly other cystic kidney diseases (Wilson
and Burrow, 1999). Hence we determined whether the
expression of E-cadherin, a key component of adherens
junctions, was affected in Spry1−/− cystic epithelia. Large
patches of cells lining the cysts in these kidneys were devoid of
E-cadherin, suggesting that they had undergone alterations in
their normal adhesive properties (Figs. 7C, D). Furthermore,
whereas the normal branching ureteric epithelium consists of a
single layer of epithelial cells (Fig. 7C), the cysts in Spry1
mutant kidneys often contained disorganized clusters of E-
cadherin negative cells, which appeared loosely attached to one
another (Fig. 7D). A recent study showed that polycystin-1/E-
cadherin-containing complexes are disrupted in human auto-
somal dominant polycystic kidney disease, resulting in deple-
tion of E-cadherin from the cell membrane (Roitbak et al.,
2004). One implication of this finding is that the loss of E-
cadherin from the cell surface may be associated with the
development of cysts. Interestingly, we could observe altera-
tions in the expression and subcellular localization of
polycystin-1 (PKD1) in cystic Spry1-deficient epithelia. Stain-
ing of normal kidney sections with an antibody to PKD1
revealed a punctate cytoplasmic localization at the basal poles
of the polarized epithelia (Supplementary Fig. 1A). By contrast,
many Spry1-deficient cystic epithelial cells seem to be
completely devoid of PKD1 (asterisks in Supplementary
Movie 1B) and some cells lining macrocysts show strong
apical localization of PKD1 (arrows in Supplementary Fig. 1).
We could not find any evidence for changes in the subcellular
localization of polycystin-2 within these cells (not shown).
Finally, we examined the integrity of epithelial basement
membrane adhesions by transmission electron microscopy
(TEM), as these were found to be abnormal in other models
of cystic kidney disease (Liu et al., 2002). We found that some
of the Spry1−/− epithelial cells have indeed lost their normal,
regular adhesion to the basement membrane (Figs. 7E, F), a
defect that may underlie the apparent loss of apical–basal
polarization.The PAX2 transcription factor is normally expressed in
immature tubular epithelial cells in the nephrogenic zone of
newborn kidneys (Fig. 7G) and down-regulated as the tubules
mature. Human cystic epithelial cells aberrantly maintain high
levels of PAX2 (Winyard et al., 1996). In Spry1−/− kidneys,
PAX2 was also present at high levels in the cystic epithelia (Fig.
7H). Cystic epithelial cells in human renal dysplasia express
abnormally high levels of activated, diphosphorylated Erk (P-
Erk) (Omori et al., 2002). As Sprouty proteins are negative
regulators of the ras/MAPK pathway (Cabrita and Christofori,
2003; Kim and Bar-Sagi, 2004), we expected cells in the Spry1
mutant to express elevated levels of activated P-Erk. Indeed,
high levels of P-Erk were readily detected in many of the
epithelial cells lining such microcysts in these kidneys (Fig. 7J),
whereas P-Erk was almost undetectable in normal kidneys (Fig.
7I). These data are in agreement with our findings on the action
of Spry1 on P-Erk activity in vitro (Fig. 5E). Elevated
expression of PAX2 and activated Erk in cystic epithelia are
associated with a hyperproliferative state (Omori et al., 2002;
Winyard et al., 1996). In agreement with this notion,
immunohistochemical analyses revealed that many Spry1−/−
cystic epithelial cells expressed high levels of phospho-histone
H3, an indicator of cells in metaphase (Figs. 7K, L). These
studies indicated that epithelial cysts that formed in Spry1−/−
kidneys share several characteristics with cysts found in human
disease.
Discussion
Through a combination of genetic and biochemical experi-
ments we have described a key function for Sprouty1 in
preventing the uncontrolled activation of a Gdnf/Ret/Wnt11
signaling loop that coordinates epithelial–mesenchymal cross-
talk during branching morphogenesis of the ureteric tree. In the
early phases of kidney development Gdnf expression in the
metanephric mesenchyme is unchanged in the absence of Spry1
(Basson et al., 2005). We now show that Gdnf expression is
augmented during later phases of kidney development, branch-
ing morphogenesis of the Spry1-deficient ureteric tree. Defects
in branching morphogenesis were detected in Spry1−/−
embryonic kidneys even if derived from a single ureteric bud.
The etiology of renal cystic diseases is highly complex and
may involve multiple signaling pathways that regulate a myriad
of cellular behaviors such as cell proliferation, apoptosis,
adhesion and polarity (Piscione and Rosenblum, 2002; Shah et
al., 2004; Wilson, 1997, 2004). Deregulation of growth factor
receptor-regulated signaling pathways may underlie the devel-
opment of a subset of these disorders. Indeed, a previous study
reported that misexpression of a ligand-independent oncogenic
isoform of the RET receptor (RET9) in the Wolffian duct led to
cystic dilation, hyperplasia and the development of renal cysts
in developing kidneys (de Graaff et al., 2001). Misexpression of
Fgf8 in the Wolffian duct also resulted in the formation of
epithelial cysts (Kuschert et al., 2001). Other growth factor
signaling systems such as EGF/TGFα/EGFR (Du and Wilson,
1995; Pugh et al., 1995) and HGF/c-Met (Takayama et al.,
1997) were also implicated in the development of cystic kidney
Fig. 8. Model of the genetic interplay between Gdnf, Ret, Wnt11 and Spry1
during ureteric bud morphogenesis. (A) Normally GDNF, expressed by
metanephric mesenchyme near the tips of the ureteric tree, locally activates
the receptor RET, resulting in Wnt11 expression only in the tip cells. WNT11 in
turn, maintains high levels of Gdnf expression in the mesenchyme surrounding
the tips. We propose that Spry1 antagonizes RET signaling, thus providing a
mechanism by which GDNF is prevented from activating RET signaling in the
connecting segments that express low levels of RET, such that it is maintained
below the threshold required for Wnt11 expression. Spry1 therefore functions to
interrupt the positive feedback loop in ureteric stalks. (B) In the absence of the
inhibitory activity of Spry1, low levels of RET activation in the UB stalk are
sufficient to induce Wnt11 expression. This ectopic Wnt11 expression can in
turn induce expression of Gdnf in the adjacent mesenchyme away from the tips
that can activate yet more RET in these non-tip cells, resulting in ectopic
branching of the ureteric epithelium.
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are largely unknown but several studies pointed to the possible
deregulation of the ras/MAPK pathway (Omori et al., 2002;
Shen and Cotton, 2003; Sorenson and Sheibani, 2002;
Yamaguchi et al., 2000).
Some studies suggested that obstruction of urinary outflow
may be an important factor in cystogenesis (Woolf et al., 2004;
Yang et al., 2001). In support of the obstruction model, we
observed larger cysts in kidney portions that were attached to
obstructed ureters in the Spry1 mutants. We showed that the
renal cysts shared several characteristics with human disease.
Notably, PAX2 and P-Erk were expressed in the cystic epithelia.
Interestingly, in studies where ureters were surgically obstructed
during fetal development, cyst formation was associated with
similar molecular alterations as observed in patients, suggesting
that many of these changes may be secondary to obstruction and
not causative (Yang et al., 2001). However we also observed
smaller cysts in regions of the Spry1 mutant kidneys associated
with a normally draining ureter, suggesting that at least some
cystic features of the Spry1 mutant kidneys were due to an
intrinsic alteration of the epithelium of the developing urinary
system. In order to formally determine whether Spry1 plays a
more direct role in cystogenesis, it would be necessary delete
this gene after E11.5 when normal ureteric bud induction had
been allowed to take place.
We also noted qualitative changes in the renal epithelium of
the Spry1 mutant mice including cysts with multiple layers of
cells and the loss of adhesion and E-cadherin expression. These
may be attributable to chronic hyperstimulation of the ras/
MAPK signaling pathway in Spry1−/− epithelial cells causing a
partial epithelial–mesenchymal transition that is associated with
the loss of E-cadherin and normal epithelial adhesion (reviewed
in Liu, 2004). Thus, while our results provide evidence for the
involvement of Spry1 in cystogenesis, the mechanism by which
epithelial cells are transformed to abnormal cystic epithelia is
likely to be multi-factorial involving ureteric obstruction with
accompanying pressure increases, hyperproliferation, abnormal
differentiation, apoptosis and changes in adhesion, polarity and
ion transport.
Our results confirm that Spry1 is an important regulator of
RET activation throughout the process of renal branching
morphogenesis. One key mechanism to prevent RET activation
in the trunks is by the restriction of high level RETexpression and
activity to the ureteric bud tips (Majumdar et al., 2003). Normally,
the lower levels of RET present in the ureteric tree trunks may not
be exposed to sufficient levels ofGDNF to activate signaling (Fig.
8). We propose that in the absence of Spry1, there is sufficient
activation of downstream signaling pathways in the trunks to
induceWnt11 expression. WNT11 produced in these connecting
segments in turn induces ectopic or elevated expression of Gdnf
in the adjacent mesenchyme (Fig. 8). The GDNF/RET/Wnt11-
positive feedback system may be imperative for orchestrating
branching morphogenesis by focusing active GDNF/RET
signaling to the tips of the ureteric buds. RET activation in the
tips of the buds results in WNT11 expression that induces more
GDNF expression locally, thus perpetuating the response. Such
positive feedback systems are frequently employed duringorganogenesis to focus proliferation at the tips of branching
epithelial tubes, providing a driving force for morphogenesis.
(Michael and Davies, 2004). Given the potentially disastrous
consequences of deregulation of such a positive feedback
mechanism, it is imperative that such a system be under strict
negative regulation. Our studies indicate that Spry1 is one gene
that serves this function during kidney development.
The mechanism by which Sprouty proteins exert their
function is only partially understood. Most studies support a
role for Sprouty proteins as antagonists of the ras/MAPK
pathway, which has been implicated in renal branching
morphogenesis (Fisher et al., 2001). We show that reducing
Spry1 levels in collecting duct cells results in hyperactivation of
the ras/MAPK pathway in response to GDNF. To our surprise,
the PI3K pathway was also hyperactive in these cells. Recent
reports have indicated effects of Sprouty proteins on this
pathway (de Alvaro et al., 2005; Edwin et al., 2006).
Interestingly, this pathway has been implicated in ureteric bud
formation and may also be employed during later branching
morphogenesis (Tang et al., 2002).
GDNF is not the only factor regulating ureteric bud
morphogenesis and kidney size. Genetic studies indicated that
Fgf7 and Fgf10 also stimulating ureteric branching (Ohuchi et
al., 2000; Qiao et al., 1999). In isolated ureteric bud culture,
GDNF cannot induce branching morphogenesis in the absence
of other soluble factors (Qiao et al., 2001; Shah et al., 2004).
Since FGF and other growth factors signal through RTK
476 M.A. Basson et al. / Developmental Biology 299 (2006) 466–477receptors, Spry1 may also potentially regulate these pathways.
Hence the phenotype of Spry1−/− kidneys may be the result of
deregulation of a number of these signals (Chi et al., 2004).
Indeed, we also observed increased mesenchymal Fgf10
expression in Spry1−/− kidneys (not shown). Nevertheless, the
striking rescue of the Spry1−/− phenotype by reducing Gdnf
gene dosage, indicates that the interplay between Gdnf and
Spry1 is crucial for normal kidney development.
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